Whether you're looking to stream more content online or just stay better protected, a VPN free trial helps make sure that the product you choose can do everything you want it to. Most of the best ...

A clinical trial is one that involves human participants and seeks to answer specific questions about a type of medical intervention. This can be a drug or other type of treatment, such as nutritional ...

The witness is giving evidence in the trial of Mr Quirke (50) of Breanshamore, County Tipperary, who has pleaded not guilty to the murder of Bobby Ryan, a part-time DJ going by the name Mr Moonlight.

NEW YORK (AP) — A New York judge set a March 2026 trial date on Monday and moved an initial conference from mid-February to next week as the public feud between Blake Lively and her “It Ends ...

It ends in court — next year. Blake Lively and Justin Baldoni are headed to trial on March 9, 2026 to settle their “It Ends With Us” legal dispute. The court date for the case was scheduled ...

The pre-pivotal clinical trial, which included 30 diabetic participants—primarily individuals with Type 1 diabetes—represents a significant milestone in Trinity's mission to deliver affordable ...

Judge Lewis J. Liman scheduled a trial date for Blake Lively and Justin Baldoni's lawsuits Benjamin VanHoose is a Staff Editor on the Movies team at PEOPLE. He has written about entertainment and ...

A Phase III trial demonstrated that adding nivolumab, an immunotherapy drug, to pre-surgery chemotherapy significantly improves cure rates for ER+/HER2− breast cancer, the most common subtype.

Wishing Bobby on his birthday, the official X (formerly Twitter) page of HHVM wrote, “Wishing the incomparable, the man of magnetic screen presence @thedeol a very Happy Birthday! - Team # ...

Justin Baldoni and Blake Lively could be headed for a trial on March 9, 2026, a judge said on Monday. The “It Ends With Us” co-stars are suing each other in federal court in New York.

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...